North America Veterinary Biomarkers Market Size & Outlook
North America veterinary biomarkers market, 2018-2030 (US$M)
Related Markets
North America veterinary biomarkers market highlights
- The North America veterinary biomarkers market generated a revenue of USD 328.0 million in 2023.
- The market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, companion animals was the largest revenue generating animal type in 2023.
- Companion Animals is the most lucrative animal type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 328.0 million |
| Market revenue in 2030 | USD 741.5 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Companion animals |
| Fastest growing segment | Companion Animals |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Companion Animals, Production Animals |
| Key market players worldwide | Zoetis, Virbac SA, Merck & Co Inc, IDEXX Laboratories Inc, Avacta Group PLC, Life Diagnostics, Mercodia, Antech Diagnostics |
Other key industry trends
- In terms of revenue, North America region accounted for 36.9% of the global veterinary biomarkers market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 379.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Biomarkers Market Scope
Veterinary Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America veterinary biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary biomarkers market will help companies and investors design strategic landscapes.
Companion animals was the largest segment with a revenue share of 61.71% in 2023. Horizon Databook has segmented the North America veterinary biomarkers market based on companion animals, production animals covering the revenue growth of each sub-segment from 2018 to 2030.
- North America Veterinary Biomarkers Animal Type Outlook (Revenue, USD Million, 2018-2030)
- Companion Animals
- Dogs
- Cats
- Others
- Production Animals
- Cows
- Pigs
- Others
- Companion Animals
- North America Veterinary Biomarkers Product Outlook (Revenue, USD Million, 2018-2030)
- Biomarkers, Kits & Reagents
- Biomarker Readers
- North America Veterinary Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Disease Diagnostics
- Preclinical Research
- Others
- North America Veterinary Biomarkers Veterinary Biomarkers Market Outlook (Revenue, USD Million, 2018-2030)
- Inflammatory & Infectious Diseases
- Cardiovascular Diseases
- Skeletal Muscle Diseases
- Tumor
- Others
Reasons to subscribe to North America veterinary biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America veterinary biomarkers market databook
-
Our clientele includes a mix of veterinary biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America veterinary biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into North America veterinary biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America veterinary biomarkers market size, by country, 2018-2030 (US$M)
North America Veterinary Biomarkers Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
